Reply to the letter to the editor on synergistic impact of insulin resistance and hepatic fibrosis on cardiovascular events in patients with coronary artery disease
No abstractNutr Metab Cardiovasc Dis. 2026 Aug 6:104954. doi: 10.1016/j.numecd.2026.104954. Online ahead of print.NO ABSTRACTPMID:42957478 | DOI:10.1016/j.numecd.2026.104954

